These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 7287903

  • 1. Effect of gastric inhibitory polypeptide on plasma levels of chylomicron triglycerides in dogs.
    Wasada T, McCorkle K, Harris V, Kawai K, Howard B, Unger RH.
    J Clin Invest; 1981 Oct; 68(4):1106-7. PubMed ID: 7287903
    [Abstract] [Full Text] [Related]

  • 2. Bethanechol prevents inhibition of gastric acid secretion by gastric inhibitory polypeptide.
    Soon-Shiong P, Debas HT, Brown JC.
    Am J Physiol; 1984 Aug; 247(2 Pt 1):G171-5. PubMed ID: 6147097
    [Abstract] [Full Text] [Related]

  • 3. The effect of gastric inhibitory polypeptide (GIP) on gastric acid secretion in dogs.
    Iinuma Y.
    Gastroenterol Jpn; 1981 Aug; 16(1):33-8. PubMed ID: 6453035
    [Abstract] [Full Text] [Related]

  • 4. Effects of amino acids and gastric inhibitory polypeptide on insulin release in dogs.
    Yovos JG, O'Dorisio TM, Pappas TN, Cataland S, Thomas FB, Mekhjian H, Carey LC.
    Am J Physiol; 1982 Jan; 242(1):E53-8. PubMed ID: 7036753
    [Abstract] [Full Text] [Related]

  • 5. Effect of endogenous gastric inhibitory polypeptide (GIP) on the removal of triacylglycerol in dogs.
    Ohneda A, Kobayashi T, Nihei J.
    Regul Pept; 1983 Apr; 6(1):25-32. PubMed ID: 6346405
    [Abstract] [Full Text] [Related]

  • 6. Peptide YY inhibits the insulinotropic action of gastric inhibitory polypeptide.
    Guo YS, Singh P, Draviam E, Greeley GH, Thompson JC.
    Gastroenterology; 1989 Mar; 96(3):690-4. PubMed ID: 2644149
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Oral glucose augmentation of insulin secretion. Interactions of gastric inhibitory polypeptide with ambient glucose and insulin levels.
    Andersen DK, Elahi D, Brown JC, Tobin JD, Andres R.
    J Clin Invest; 1978 Jul; 62(1):152-61. PubMed ID: 659629
    [Abstract] [Full Text] [Related]

  • 16. Minor Contribution of Endogenous GLP-1 and GLP-2 to Postprandial Lipemia in Obese Men.
    Matikainen N, Björnson E, Söderlund S, Borén C, Eliasson B, Pietiläinen KH, Bogl LH, Hakkarainen A, Lundbom N, Rivellese A, Riccardi G, Després JP, Alméras N, Holst JJ, Deacon CF, Borén J, Taskinen MR.
    PLoS One; 2016 Jul; 11(1):e0145890. PubMed ID: 26752550
    [Abstract] [Full Text] [Related]

  • 17. Enhancement of insulin secretory response to glucose-dependent insulinotropic polypeptide (GIP) by growth hormone in dogs.
    Pierluissi J, de Pierluissi R, de Martínez A.
    Acta Cient Venez; 2002 Jul; 53(1):29-35. PubMed ID: 12216497
    [Abstract] [Full Text] [Related]

  • 18. Gastric inhibitory polypeptide. Its physiologic release and insulinotropic action in the dog.
    Pederson RA, Schubert HE, Brown JC.
    Diabetes; 1975 Dec; 24(12):1050-6. PubMed ID: 1193309
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The effect of gastric inhibitory polypeptide on human jejunal water and electrolyte transport.
    Helman CA, Barbezat GO.
    Gastroenterology; 1977 Feb; 72(2):376-9. PubMed ID: 830596
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.